Sunday, October 24, 2021
HomeArtificial IntelligenceDigital Therapeutics Market Is Expected To Reach US$ 8.5 Bn By 2025

Digital Therapeutics Market Is Expected To Reach US$ 8.5 Bn By 2025

The latest market report published by Acute Market Reports “Digital Therapeutics Market: Growth, Future Prospects, and Competitive Analysis, 2017 -2025” the global digital therapeutics market was valued at US$ 1.3 Bn in 2016, and is expected to reach US$ 8.5 Bn by 2025, expanding at a CAGR of 23.2% from 2017 to 2025.

Market Insights

Digital therapeutics are technology-based health management solutions to treat chronic health conditions by assisting patients to make behavioral alternations to lead improved clinical conditions. Digital therapeutics majorly consists of software solutions that are deployed to the patients along with services such as disease/medication management, patient-clinician communication, fitness/wellness tracking, social support, medical guidance and education, insurance search and professional search pertaining to practitioners. Digital therapeutics helps in bridging patients, payers and caregivers together thus contributing to better treatment outcomes with reduced healthcare cost. This platform plays a major role in the chronic diseases management owing to the need for monitoring and management for a longer duration of time and their continuous rise in prevalence at present and during the forecast period.

Browse the full report Digital Therapeutics Market: Growth, Future Prospects, and Competitive Analysis, 2017 -2025 report at https://www.acutemarketreports.com/report/digital-therapeutics-market

Every 1 in 2 adults in the U.S. are prevalent with chronic diseases as per the Centers of Disease Control and Prevention (CDC). The Organization for Economic Co-operation and Development (OECD) mentions the occurrence of 550,000 premature deaths annually in Europe in working population, which is a consequence of chronic diseases. Diabetes mellitus accounts for the second largest market amongst the chronic diseases and comprises predominant usage of subcutaneous route of administration. According to the International Diabetes Federation (IDF), the global prevalence of diabetes was found to be 415 million in 2015 and is expected to increase to 642 million by the year 2040. According to the WHO, 13% of the world population suffered from obesity in the year 2016. Such high prevalence of chronic diseases has led to increase in demand for better therapeutic options with positive treatment outcomes, thus driving the digital therapeutics market growth. Amongst diabetes patients, insulin medication is carried out for a longer duration of time with higher frequency. Such long term medications for a higher frequency majorly accounts for non-adherence and tampers the therapeutic benefits and also effects the overall healthcare cost. As per the Centers of Disease Control and Prevention (CDC), in U.S. there has been a substantial increase in the hospital admission rates up to 69% by non-adherent patients with chronic illness in the year 2016. Digital therapeutics platforms help in reducing non-adherence and increasing the treatment outcome amongst patients, which is driving the market.

North America accounts for the major share in the digital therapeutic market due to increasing number of digital therapeutic software companies and growing investment in this sector. The U.S. FDA approved its first mobile prescription therapy called BlueStar from WellDoC for managing diabetes. Rise in expansion of healthcare infrastructure with improving reimbursement policies, drive towards attaining a patient-centric healthcare approach and technological advancements in healthcare monitoring are the major factors that North America this market. Asia Pacific is expected to grow at a faster rate in the forecast period, 2017-2025. This growth is attributed to factors such as increasing population, which provides the digital therapeutics market a large target base, increase in availability of technology and adoption of newer healthcare technologies. In addition, constant reforms to develop better healthcare infrastructure and maintain sustainable healthcare growth by financial inclusions is expected to drive this market.

Request Sample Copy of Complete Research @ https://www.acutemarketreports.com/request-free-sample/137816

Market Competition Assessment:

The digital therapeutics market comprises an extensive pool of market players.  This market encompasses several leaders dominating this market with their innovative technologies. The major market players in this market are Omada Health, Inc., Doximity, Inc., Evolent Health, Inc., Perfint Healthcare Pvt. Ltd., Zest Health, Pear Therapeutics, Inc., Nanobiosym, Inc., WellDoc Inc., Proteus Digital Health, 2Morrow, Inc., Propeller Health, Livongo Health, Twinehealth, Inc., Mango Health, Inc., Noom Health, Inc. Canary Health, Inc., & others.

Key Market Movements:

  • There is an increasing demand for digital therapeutic techniques owing to its ability to monitor treatment regimens by setting reminders for prescribed medication and recording consumed medications, thus ensuring adherence to medication which reflects positive treatment outcomes
  • An increasing need for reduced healthcare spending, with better therapeutic outcomes drives the digital therapeutic market
  • Rise in healthcare IT infrastructure accounts for more advanced products thus creating a demand for it

Table of Contents

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Digital Therapeutics Market Portraiture
2.1.1. Global Digital Therapeutics Market, by Product Type, 2016 (US$ Mn)
2.1.2. Global Digital Therapeutics Market, by Application, 2016 (US$ Mn)
2.1.3. Global Digital Therapeutics Market, by Geography, 2016 vs. 2025 (US$ Mn)

Chapter 3. Global Digital Therapeutics Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Digital Therapeutics: Future Trends
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2016
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Digital Therapeutics Market, by Product Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Digital Therapeutics Market, by Product Type , 2016
4.2. Software
4.3. Devices
4.3.1. Pain management Devices
4.3.2. Rehabilitation Devices
4.3.3. Respiratory Therapy Devices
4.3.4. Glucose Monitoring Devices

Chapter 5. Global Digital Therapeutics Market, by Application , 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Digital Therapeutics Market, byApplication Type, 2016
5.2. Diabetes
5.3. Obesity
5.4. Cardiovascular Diseases
5.5. CNS Diseases
5.6. Respiratory Diseases
5.7. Smoking Cessation
5.8. Others

Chapter 6. Global Digital Therapeutics Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Digital Therapeutics Market Analysis, 2015 – 2025
6.2.1. North America Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
6.2.2. North America Digital Therapeutics Market, by Application , 2015 – 2025(US$ Mn)
6.2.3. North America Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Digital Therapeutics Market Analysis, 2015 – 2025
6.3.1. Europe Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
6.3.2. Europe Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
6.3.3. Europe Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Digital Therapeutics Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
6.4.2. Asia Pacific Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
6.4.3. Asia Pacific Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America Digital Therapeutics Market Analysis, 2015 – 2025
6.5.1. Latin America Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
6.5.2. Latin America Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
6.5.3. Latin America Digital Therapeutics Market, by Country, 2015 – 2025(US$ Mn)
6.5.3.1. Mexico
6.5.3.2. Brazil
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Digital Therapeutics Market Analysis, 2015 – 2025
6.6.1. MEA Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
6.6.2. MEA Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
6.6.3. MEA Digital Therapeutics Market, by Country, 2015 – 2025(US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. 2Morrow, Inc.
7.1.1. Business Description
7.1.2. Financial Information(Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Canary Health, Inc.
7.3. Doximity, Inc.
7.4. Evolent Health, Inc.
7.5. Livongo Health
7.6. Mango Health, Inc.
7.7. Nanobiosym, Inc.
7.8. Noom Health, Inc.
7.9. Omada Health, Inc.
7.10. Pear Therapeutics, Inc.
7.11. Perfint Healthcare Pvt. Ltd.
7.12. Propeller Health
7.13. Proteus Digital Health
7.14. Twinehealth, Inc.
7.15. WellDoc Inc.
7.16. Zest Health

List Of Tables

TABLE 1 Global Digital Therapeutics Market Share, by Product Type, 2016 (US$ Mn)
TABLE 2 Global Digital Therapeutics Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 3 Global Digital Therapeutics Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 4 North America Digital Therapeutics Market, by Product Type , 2015 – 2025(US$ Mn)
TABLE 5 North America Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
TABLE 6 North America Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 8 Europe Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
TABLE 9 Europe Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Asia Pacific Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 11 Asia Pacific Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
TABLE 12 Asia Pacific Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Latin America Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 14 Mn)
TABLE 15 Latin America Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
TABLE 16 Latin America Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 17 Middle East And Africa Digital Therapeutics Market, by Product Type, 2015 – 2025(US$ Mn)
TABLE 18 (US$ Mn)
TABLE 19 Middle East And Africa Digital Therapeutics Market, by Application, 2015 – 2025(US$ Mn)
TABLE 20 Middle East And Africa Digital Therapeutics Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 2Morrow, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Canary Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Doximity, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Evolent Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Livongo Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Mango Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Nanobiosym, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Noom Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Omada Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Pear Therapeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Perfint Healthcare Pvt. Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Propeller Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 Proteus Digital Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Twinehealth, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 WellDoc Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 36 Zest Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

About Us

Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.

Contact

Acute Market Reports
Address: 90 Church St, FL 1 #3514,
New York, NY 10008 United States
Toll Free(US/CANADA): +1-855-455-8662
E-mail: sales@acutemarketreports.com

Most Popular